{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:12:08Z","timestamp":1793351528673,"version":"4.5.0"},"reference-count":292,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006595","name":"Executive Unit for Financing Higher Education Research Development and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006595","name":"UEFISCDI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ejps.2025.107036","type":"journal-article","created":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T02:46:36Z","timestamp":1738982796000},"page":"107036","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Cannabidiol\u2014A friend or a foe?"],"prefix":"10.1016","volume":"208","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6288-0267","authenticated-orcid":false,"given":"Bianca \u2013 Maria","family":"Tih\u0103uan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Onisei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Slootweg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Gun\u0103","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7042-5248","authenticated-orcid":false,"given":"Ciprian","family":"Iliescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana \u2013 Carmen","family":"Chifiriuc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ejps.2025.107036_bib0001","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1021\/ja01866a040","article-title":"Structure of cannabidiol. VI. Isomerization of cannabidiol to tetrahydrocannabinol, a physiologically active product. Conversion of cannabidiol to cannabinol","volume":"62","author":"Adams","year":"1940","journal-title":"J. Am. Chem. Soc."},{"issue":"April","key":"10.1016\/j.ejps.2025.107036_bib0002","first-page":"32","article-title":"Medicinal cannabis policies and practices around the world","author":"Aguilar","year":"2018","journal-title":"Int. Drug Policy Consort"},{"issue":"10","key":"10.1016\/j.ejps.2025.107036_bib0003","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1007\/BF02085029","article-title":"Interactions of delta 1-tetrahydrocannabinol with cannabinol and cannabidiol following oral administration in man. Assay of cannabinol and cannabidiol by mass fragmentography","volume":"37","author":"Agurell","year":"1981","journal-title":"Experientia"},{"issue":"4","key":"10.1016\/j.ejps.2025.107036_bib0004","first-page":"438","article-title":"Transdermal drug delivery: innovative pharmaceutical developments based on disruption of the barrier properties of the stratum corneum","volume":"7","author":"Alkilani","year":"2015","journal-title":"Pharm"},{"issue":"1","key":"10.1016\/j.ejps.2025.107036_bib0005","first-page":"605","article-title":"Design for optimisation of drug administration","volume":"9","author":"Amato","year":"2024","journal-title":"J. Heal. Des."},{"issue":"4","key":"10.1016\/j.ejps.2025.107036_bib0006","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/ecco-jcc\/jjy185","article-title":"Cannabis, cannabinoids, and the endocannabinoid system\u2014Is there therapeutic potential for inflammatory bowel disease?","volume":"13","author":"Ambrose","year":"2019","journal-title":"J. Crohns. Colitis"},{"issue":"11","key":"10.1016\/j.ejps.2025.107036_bib0007","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1111\/epi.16355","article-title":"Coadministered cannabidiol and clobazam: preclinical evidence for both pharmacodynamic and pharmacokinetic interactions","volume":"60","author":"Anderson","year":"2019","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.ejps.2025.107036_bib0008","first-page":"241","article-title":"Cannabis sativa: the plant of the thousand and one molecules","volume":"7","author":"Andre","year":"2016","journal-title":"Front. Plant Sci."},{"key":"10.1016\/j.ejps.2025.107036_bib0009","first-page":"1500","article-title":"Medical cannabis activity against inflammation: active compounds and modes of action","volume":"0","author":"Anil","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejps.2025.107036_bib0010","unstructured":"\u201cAntimicrobial Studies of Cannabidiol as biomaterials against superbug MRSA | CMBES proceedings.\u201d https:\/\/proceedings.cmbes.ca\/index.php\/proceedings\/article\/view\/915 (accessed May 18, 2022)."},{"key":"10.1016\/j.ejps.2025.107036_bib0011","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ejpb.2018.11.020","article-title":"Lipid nanocapsules decorated and loaded with cannabidiol as targeted prolonged release carriers for glioma therapy: In vitro screening of critical parameters","volume":"134","author":"Aparicio-Blanco","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"4","key":"10.1016\/j.ejps.2025.107036_bib0012","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/YCO.0000000000000616","article-title":"Current cannabis-related situation in the Asia-Pacific region","volume":"33","author":"Areesantichai","year":"2020","journal-title":"Curr. Opin. Psychiatry"},{"issue":"6","key":"10.1016\/j.ejps.2025.107036_bib0013","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/2045125312457586","article-title":"Cannabis, a complex plant: different compounds and different effects on individuals","volume":"2","author":"Atakan","year":"2012","journal-title":"Ther. Adv. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.ejps.2025.107036_bib0014","doi-asserted-by":"crossref","DOI":"10.3390\/antiox9010021","article-title":"Antioxidative and anti-inflammatory properties of cannabidiol","volume":"9","author":"Atalay","year":"2020","journal-title":"Antioxidants"},{"issue":"3","key":"10.1016\/j.ejps.2025.107036_bib0015","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1476-5381.2010.00729.x","article-title":"CB2: a cannabinoid receptor with an identity crisis","volume":"160","author":"Atwood","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.ejps.2025.107036_bib0016","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/jpp\/rgae043","article-title":"3D DLP-printed cannabinoid microneedles patch and its pharmacokinetic evaluation in rats","volume":"76","author":"Bagde","year":"2024","journal-title":"J. Pharm. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejps.2025.107036_bib0017","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1177\/0253717620957501","article-title":"From \u2018Bhang shops\u2019 to \u2018Cannabis in Coffee shops\u2019: time to debate the option?","volume":"44","author":"Balhara","year":"2020","journal-title":"Indian J. Psychol. Med."},{"issue":"3","key":"10.1016\/j.ejps.2025.107036_bib0018","first-page":"178","article-title":"Pharmacokinetics of cannabidiol administered by 3 delivery methods at 2 different dosages to healthy dogs","volume":"82","author":"Bartner","year":"2018","journal-title":"Can. J. Vet. Res."},{"issue":"1","key":"10.1016\/j.ejps.2025.107036_bib0019","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s12026-011-8210-5","article-title":"Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and disease","volume":"51","author":"Basu","year":"2011","journal-title":"Immunol. Res."},{"key":"10.1016\/j.ejps.2025.107036_bib0020","doi-asserted-by":"crossref","first-page":"927","DOI":"10.2147\/CCID.S286411","article-title":"Therapeutic potential of cannabidiol (CBD) for skin health and disorders","volume":"13","author":"Baswan","year":"2020","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"10.1016\/j.ejps.2025.107036_bib0021","doi-asserted-by":"crossref","first-page":"927","DOI":"10.2147\/CCID.S286411","article-title":"Therapeutic potential of cannabidiol (CBD) for skin health and disorders","volume":"13","author":"Baswan","year":"2020","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"issue":"6","key":"10.1016\/j.ejps.2025.107036_bib0022","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s40263-020-00726-4","article-title":"A phase II randomized trial to explore the potential for pharmacokinetic drug\u2013Drug interactions with stiripentol or valproate when combined with cannabidiol in patients with epilepsy","volume":"34","author":"Ben-Menachem","year":"2020","journal-title":"CNS Drugs"},{"issue":"20","key":"10.1016\/j.ejps.2025.107036_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules26206257","article-title":"Safety of medical cannabis in neuropathic chronic pain management","volume":"26","author":"Bennici","year":"2021","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.ejps.2025.107036_bib0024","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/clpt.1980.139","article-title":"Metabolic and psychophysiologic studies of cannabidiol-hexobarbital interaction","volume":"28","author":"Benowitz","year":"1980","journal-title":"Clin. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.ejps.2025.107036_bib0025","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/npp.2011.6","article-title":"Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-na\u00efve social phobia patients","volume":"36","author":"Bergamaschi","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.ejps.2025.107036_bib0026","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/npp.2009.184","article-title":"Opposite effects of \u03b4-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology","volume":"35","author":"Bhattacharyya","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.ejps.2025.107036_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-020-01530-y","article-title":"The antimicrobial potential of cannabidiol","volume":"4","author":"Blaskovich","year":"2021","journal-title":"Commun. Biol."},{"issue":"4","key":"10.1016\/j.ejps.2025.107036_bib0028","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s13311-015-0387-1","article-title":"Cannabidiol as a potential treatment for anxiety disorders","volume":"12","author":"Blessing","year":"2015","journal-title":"Neurotherapeutics"},{"issue":"6","key":"10.1016\/j.ejps.2025.107036_bib0029","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1111\/bph.12043","article-title":"Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT1A receptor activation","volume":"168","author":"Bolognini","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejps.2025.107036_bib0030","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.cocis.2012.02.001","article-title":"Penetration of drugs through skin, a complex rate-controlling membrane","volume":"17","author":"Bolzinger","year":"2012","journal-title":"Curr. Opin. Colloid. Interface Sci."},{"issue":"5","key":"10.1016\/j.ejps.2025.107036_bib0031","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0006-2952(81)90636-5","article-title":"Effect of cannabidiol on cytochrome P-450 and hexobarbital sleep time","volume":"30","author":"Bornheim","year":"1981","journal-title":"Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.ejps.2025.107036_bib0032","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0006-2952(93)90286-6","article-title":"Characterization of cannabidiol-mediated cytochrome P450 inactivation","volume":"45","author":"Bornheim","year":"1993","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejps.2025.107036_bib0033","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1476-5381.1979.tb16111.x","article-title":"Development of tolerance to the prolongation of Hexobarbitone sleeping time caused by Cannabidiol","volume":"67","author":"Borys","year":"1979","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.ejps.2025.107036_bib0034","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s11916-024-01252-4","article-title":"Cannabinoids for acute pain management: approaches and rationale","volume":"28","author":"Botea","year":"2024","journal-title":"Curr. Pain Headache Rep."},{"issue":"MAR","key":"10.1016\/j.ejps.2025.107036_bib0035","first-page":"108","article-title":"Cannabis in Chinese medicine: are some traditional indications referenced in ancient literature related to cannabinoids?","volume":"8","author":"Brand","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"7","key":"10.1016\/j.ejps.2025.107036_bib0036","doi-asserted-by":"crossref","first-page":"989","DOI":"10.3390\/jcm8070989","article-title":"Potential adverse drug events and drug\u2013Drug interactions with medical and consumer cannabidiol (CBD) use","volume":"8","author":"Brown","year":"2019","journal-title":"J. Clin. Med."},{"issue":"7","key":"10.1016\/j.ejps.2025.107036_bib0037","doi-asserted-by":"crossref","first-page":"989","DOI":"10.3390\/jcm8070989","article-title":"Potential adverse drug events and drug\u2013Drug interactions with medical and consumer cannabidiol (CBD) use","volume":"8","author":"Brown","year":"2019","journal-title":"J. Clin. Med."},{"issue":"10","key":"10.1016\/j.ejps.2025.107036_bib0038","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23102478","article-title":"Cannabinoid delivery systems for pain and inflammation treatment","volume":"23","author":"Bruni","year":"2018","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.ejps.2025.107036_bib0039","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/pharmaceutics9020012","article-title":"Liposomal formulations in clinical use: an updated review","volume":"9","author":"Bulbake","year":"2017","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2025.107036_bib0040","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/978-3-319-20825-1_6","article-title":"Endocannabinoids and the immune system in health and disease","volume":"231","author":"Cabral","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.ejps.2025.107036_bib0041","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.3389\/fphys.2021.785176","article-title":"Cannabinoid therapeutics in chronic neuropathic pain: from animal research to Human treatment","volume":"12","author":"Campos","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ejps.2025.107036_bib0042","article-title":"A-synaptic technologies for the delivery of cannabinoids","author":"Canada","year":"2020","journal-title":"Technol. Platform,"},{"key":"10.1016\/j.ejps.2025.107036_bib0043","unstructured":"\u201cCannabidiol (CBD): Analyse de situation - International Drug Policy Consortium (IDPC).\u201d https:\/\/idpc.net\/fr\/publications\/2019\/02\/cannabidiol-cbd-analyse-de-situation (accessed Jan. 19, 2023)."},{"key":"10.1016\/j.ejps.2025.107036_bib0044","unstructured":"\u201cCannabidiol | C21H30O2 - PubChem.\u201d https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Cannabidiol (accessed May 19, 2021)."},{"key":"10.1016\/j.ejps.2025.107036_bib0045","unstructured":"\u201cCannabis law and legislation in South Africa | CMS Expert Guides.\u201d https:\/\/cms.law\/en\/int\/expert-guides\/cms-expert-guide-to-a-legal-roadmap-to-cannabis\/south-africa?utm_source=chatgpt.com (accessed Jan. 17, 2025)."},{"key":"10.1016\/j.ejps.2025.107036_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101321","article-title":"Cannabidiol induces antioxidant pathways in keratinocytes by targeting BACH1","volume":"28","author":"Casares","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejps.2025.107036_bib0047","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3389\/fphar.2020.00124","article-title":"From cannabis sativa to cannabidiol: promising therapeutic candidate for the treatment of neurodegenerative diseases","volume":"11","author":"Cassano","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejps.2025.107036_bib0048","unstructured":"\u201cCayman Islands to ask voters whether to ease marijuana laws | AP News.\u201d https:\/\/apnews.com\/article\/cayman-islands-marijuana-decriminalize-possession-8b1eaa62bf9bd850635a76f5a7484c73 (accessed Jan. 17, 2025)."},{"key":"10.1016\/j.ejps.2025.107036_bib0049","unstructured":"\u201cCBD Skin Care Market Size, Share & trends | research report by 2026.\u201d https:\/\/www.alliedmarketresearch.com\/cbd-skin-care-market (accessed Oct. 05, 2022)."},{"issue":"May","key":"10.1016\/j.ejps.2025.107036_bib0050","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.2147\/IJN.S452207","article-title":"Nanosuspension-loaded dissolving microneedle patches for enhanced transdermal delivery of a highly lipophilic cannabidiol","volume":"19","author":"Cheng","year":"2024","journal-title":"Int. J. Nanomed."},{"issue":"4","key":"10.1016\/j.ejps.2025.107036_bib0051","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3233\/JAD-140921","article-title":"Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimer's disease transgenic mice","volume":"42","author":"Cheng","year":"2014","journal-title":"J. Alzheimers. Dis."},{"key":"10.1016\/j.ejps.2025.107036_bib0052","unstructured":"\u201cCJEU landmark ruling confirms that CBD is not a narcotic drug and that member states may not prohibit its marketing - A&O Shearman.\u201d https:\/\/www.aoshearman.com\/en\/insights\/ao-shearman-on-life-sciences\/cjeu-landmark-ruling-confirms-cbd-not-narcotic-drug-and-member-states-may-not-prohibit-marketing (accessed Dec. 04, 2024)."},{"key":"10.1016\/j.ejps.2025.107036_bib0053","unstructured":"\u201cClinical Trials register - Cannabidiol.\u201d https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/search?query=Cannabidiol&status=completed&status=ongoing (accessed Nov. 22, 2023)."},{"key":"10.1016\/j.ejps.2025.107036_bib0054","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.3389\/fphar.2020.587604","article-title":"Medium-dose chronic cannabidiol treatment reverses object recognition memory deficits of APP swe \/PS1\u0394E9 transgenic female mice","volume":"11","author":"Coles","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejps.2025.107036_bib0055","unstructured":"\u201cCONTROVERSATUL CANNABIS Riscuri \u0219i beneficii - Univers Farmaceutic.\u201d https:\/\/www.universfarmaceutic.ro\/amfiteatru\/controversatul-cannabis-riscuri-si-beneficii (accessed Aug. 26, 2022)."},{"issue":"5 PART 1","key":"10.1016\/j.ejps.2025.107036_bib0056","article-title":"Regulation no 1223\/2009 on cosmetic products","volume":"29","author":"Couteau","year":"2010","journal-title":"Nouv. Dermatol."},{"issue":"189","key":"10.1016\/j.ejps.2025.107036_bib0057","first-page":"48950","article-title":"Schedules of controlled substances: placement in schedule V of certain FDA-approved drugs containing cannabidiol; corresponding change to permit requirements. Final order","volume":"83","year":"2018","journal-title":"Fed. Regist."},{"key":"10.1016\/j.ejps.2025.107036_bib0058","unstructured":"\u201cDAC\/NRF: Rezepturtipp der Woche 51\/2015.\u201d https:\/\/dacnrf.pharmazeutische-zeitung.de\/fuer-abonnenten\/rezepturtipp\/rezepturtipps-2015\/neu-in-dac\/nrf-cannabidiol (accessed Oct. 05, 2022)."},{"issue":"3","key":"10.1016\/j.ejps.2025.107036_bib0059","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/cpt1976193300","article-title":"Influence of cannabidiol on delta-9-tetrahydrocannabinol effects","volume":"19","author":"Dalton","year":"1976","journal-title":"Clin. Pharmacol. Ther."},{"issue":"10","key":"10.1016\/j.ejps.2025.107036_bib0060","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1007\/s00210-020-01878-2","article-title":"The effect of cannabidiol on the pharmacokinetics of carbamazepine in rats","volume":"393","author":"Darweesh","year":"2020","journal-title":"Naunyn. Schmiedebergs. Arch. Pharmacol."},{"key":"10.1016\/j.ejps.2025.107036_bib0061","doi-asserted-by":"crossref","DOI":"10.1177\/2045125319881916","article-title":"Cannabidiol as a potential treatment for psychosis","volume":"9","author":"Davies","year":"2019","journal-title":"Ther. Adv. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.ejps.2025.107036_bib0062","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/0269881119895536","article-title":"Effects of acute cannabidiol administration on anxiety and tremors induced by a Simulated Public Speaking Test in patients with Parkinson's disease","volume":"34","author":"de Faria","year":"2020","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ejps.2025.107036_bib0063","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jcis.2022.12.036","article-title":"Encapsulation of cannabidiol in oil-in-water nanoemulsions and nanoemulsion-filled hydrogels: A structure and biological assessment study","volume":"634","author":"Demisli","year":"2023","journal-title":"J. Colloid Interface Sci."},{"issue":"6","key":"10.1016\/j.ejps.2025.107036_bib0064","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/ane.13305","article-title":"Cannabidiol efficacy independent of clobazam: meta-analysis of four randomized controlled trials","volume":"142","author":"Devinsky","year":"2020","journal-title":"Acta Neurol. Scand."},{"issue":"5","key":"10.1016\/j.ejps.2025.107036_bib0065","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/nrd2553","article-title":"Targeting the endocannabinoid system: to enhance or reduce?","volume":"7","author":"Di Marzo","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejps.2025.107036_bib0066","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4938154","article-title":"The efficacy and safety of antipsychotic medications in the treatment of psychosis in patients with Parkinson's disease","volume":"2016","author":"Divac","year":"2016","journal-title":"Behav. Neurol."},{"issue":"2","key":"10.1016\/j.ejps.2025.107036_bib0067","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/jcpt.12235","article-title":"Phytocannabinoids and epilepsy","volume":"40","author":"Dos Santos","year":"2015","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.ejps.2025.107036_bib0068","unstructured":"\u201cDrugs (psychoactive): Cannabidiol (compound of cannabis).\u201d https:\/\/www.who.int\/news-room\/questions-and-answers\/item\/cannabidiol-(compound-of-cannabis) (accessed Aug. 27, 2022)."},{"key":"10.1016\/j.ejps.2025.107036_bib0069","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.toxrep.2020.02.014","article-title":"Safety assessment of a hemp extract using genotoxicity and oral repeat-dose toxicity studies in Sprague-Dawley rats","volume":"7","author":"Dziwenka","year":"2020","journal-title":"Toxicol. Rep."},{"issue":"2","key":"10.1016\/j.ejps.2025.107036_bib0070","first-page":"88","article-title":"The health effects of cannabis and cannabinoids","volume":"15","year":"2017","journal-title":"Psychiatria"},{"key":"10.1016\/j.ejps.2025.107036_bib0071","unstructured":"\u201cEffects of THC-free CBD oil on agitation in patients with Alzheimer's disease - full text view - ClinicalTrials.Gov.\u201d https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04436081 (accessed May 18, 2022)."},{"key":"10.1016\/j.ejps.2025.107036_bib0072","doi-asserted-by":"crossref","unstructured":"M.F. El-Azab, A.E. Wakiel, Y.K. Nafea, and M.E. Youssef, \u201cRole of cannabinoids and the endocannabinoid system in modulation of diabetic cardiomyopathy,\u201d http:\/\/www.wjgnet.com\/, vol. 13, no. 5, pp. 387\u2013407, May 2022, doi: 10.4239\/WJD.V13.I5.387.","DOI":"10.4239\/wjd.v13.i5.387"},{"issue":"AUG","key":"10.1016\/j.ejps.2025.107036_bib0073","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.3389\/fimmu.2018.01782","article-title":"Cannabidiol attenuates experimental autoimmune encephalomyelitis model of multiple sclerosis through induction of myeloid-derived suppressor cells","volume":"9","author":"Elliott","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.ejps.2025.107036_bib0074","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2353\/ajpath.2006.050500","article-title":"Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes","volume":"168","author":"El-Remessy","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejps.2025.107036_bib0075","unstructured":"European Medicines Agency (EMA), \u201cCommittee for Medicinal Products for Human Use (CHMP) Assessment report,\u201d 2019. [Online]. Available: www.ema.europa.eu\/contact."},{"issue":"9","key":"10.1016\/j.ejps.2025.107036_bib0076","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24091694","article-title":"Hepatotoxicity of a cannabidiol-rich cannabis extract in the mouse model","volume":"24","author":"Ewing","year":"2019","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.ejps.2025.107036_bib0077","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/phar.1780","article-title":"Current status and prospects for cannabidiol preparations as new therapeutic agents","volume":"36","author":"Fasinu","year":"2016","journal-title":"Pharmacotherapy"},{"issue":"12","key":"10.1016\/j.ejps.2025.107036_bib0078","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1007\/s00204-016-1664-4","article-title":"Genotoxic properties of XLR-11, a widely consumed synthetic cannabinoid, and of the benzoyl indole RCS-4","volume":"90","author":"Ferk","year":"2016","journal-title":"Arch. Toxicol."},{"issue":"2","key":"10.1016\/j.ejps.2025.107036_bib0079","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2125.2012.04341.x","article-title":"Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?","volume":"75","author":"Fern\u00e1ndez-Ruiz","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejps.2025.107036_bib0080","article-title":"Skin applications of cannabidiol: sources, effects, delivery systems","volume":"22","author":"Ferreira","year":"2023","journal-title":"Market.Formul. Saf."},{"issue":"3","key":"10.1016\/j.ejps.2025.107036_bib0081","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s11101-023-09860-5","article-title":"Skin applications of cannabidiol: sources, effects, delivery systems, marketed formulations and safety","volume":"22","author":"Ferreira","year":"2023","journal-title":"Phytochem. Rev."},{"issue":"7","key":"10.1016\/j.ejps.2025.107036_bib0082","first-page":"1049","article-title":"The skin and natural cannabinoids\u2013Topical and transdermal applications","volume":"16","author":"Filipiuc","year":"2023","journal-title":"Pharm"},{"key":"10.1016\/j.ejps.2025.107036_bib0083","unstructured":"\u201cForty-first meeting of the Expert Committee on Drug Dependence.\u201d https:\/\/www.who.int\/news-room\/events\/detail\/2018\/11\/12\/default-calendar\/forty-first-meeting-of-the-expert-committee-on-drug-dependence (accessed May 20, 2021)."},{"issue":"7","key":"10.1016\/j.ejps.2025.107036_bib0084","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1021\/acs.molpharmaceut.3c00044","article-title":"Micelles-in-liposome systems obtained by proliposomal approach for cannabidiol delivery: structural features and skin penetration","volume":"20","author":"Franz\u00e8","year":"2023","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.ejps.2025.107036_bib0085","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00432824","article-title":"The effect of \u03949, cannabidiol, and cannabinol on the anaesthesia induced by various anaesthetic agents in mice","volume":"55","author":"Frizza","year":"1977","journal-title":"Psychopharmacology (Berl.)"},{"issue":"2","key":"10.1016\/j.ejps.2025.107036_bib0086","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11481-021-09982-7","article-title":"Immunomodulatory potential of cannabidiol in multiple sclerosis: a systematic review","volume":"16","author":"Furgiuele","year":"2021","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.ejps.2025.107036_bib0087","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.3389\/fphar.2021.762738","article-title":"Reviewing the role of the endocannabinoid system in the pathophysiology of depression","volume":"12","author":"Gallego-Landin","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejps.2025.107036_bib0088","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1111\/jocd.14263","article-title":"Novel cannabidiol aspartame combination treatment (JW-100) significantly reduces ISGA score in atopic dermatitis: results from a randomized double-blinded placebo-controlled interventional study","volume":"21","author":"Gao","year":"2022","journal-title":"J. Cosmet. Dermatol."},{"issue":"5","key":"10.1016\/j.ejps.2025.107036_bib0089","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/pr.2016.149","article-title":"Short-term effects of cannabidiol after global hypoxia-ischemia in newborn piglets","volume":"80","author":"Garberg","year":"2016","journal-title":"Pediatr. Res."},{"issue":"11","key":"10.1016\/j.ejps.2025.107036_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biom10111575","article-title":"Cannabidiol: A potential new alternative for the treatment of Anxiety, Depression, and psychotic disorders","volume":"10","author":"Garc\u00eda-Guti\u00e9rrez","year":"2020","journal-title":"Biomolecules"},{"issue":"8","key":"10.1016\/j.ejps.2025.107036_bib0091","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/epi.13060","article-title":"Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy","volume":"56","author":"Geffrey","year":"2015","journal-title":"Epilepsia"},{"issue":"8","key":"10.1016\/j.ejps.2025.107036_bib0092","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/epi.13060","article-title":"Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy","volume":"56","author":"Geffrey","year":"2015","journal-title":"Epilepsia"},{"issue":"11","key":"10.1016\/j.ejps.2025.107036_bib0093","doi-asserted-by":"crossref","first-page":"18781","DOI":"10.3390\/molecules191118781","article-title":"Cannabinoids: new promising agents in the treatment of neurological diseases","volume":"19","author":"Giacoppo","year":"2014","journal-title":"Mol."},{"key":"10.1016\/j.ejps.2025.107036_bib0094","unstructured":"B. Gibbs, A. Yates, and J. Liebling, \u201cCbd in the Uk,\u201d 2019."},{"key":"10.1016\/j.ejps.2025.107036_bib0095","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.seizure.2020.09.010","article-title":"Interaction of cannabidiol with other antiseizure medications: A narrative review","volume":"86","author":"Gilmartin","year":"2021","journal-title":"Seizure"},{"issue":"1\u20133","key":"10.1016\/j.ejps.2025.107036_bib0096","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.schres.2015.01.015","article-title":"Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol","volume":"164","author":"Gomes","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ejps.2025.107036_bib0097","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jconrel.2015.10.049","article-title":"Nanoparticles and nanofibers for topical drug delivery","volume":"240","author":"Goyal","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2025.107036_bib0098","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ebcr.2017.10.001","article-title":"An interaction between warfarin and cannabidiol, a case report","volume":"9","author":"Grayson","year":"2017","journal-title":"Epilepsy Behav. Case Rep."},{"issue":"18","key":"10.1016\/j.ejps.2025.107036_bib0099","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27186070","article-title":"Promising nanocarriers to enhance solubility and bioavailability of cannabidiol for a plethora of therapeutic opportunities","volume":"27","author":"Grifoni","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejps.2025.107036_bib0100","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.3389\/fphar.2021.725136","article-title":"Cannabidiol induces apoptosis and perturbs mitochondrial function in Human and canine glioma cells","volume":"12","author":"Gross","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejps.2025.107036_bib0101","first-page":"e7","article-title":"Pharmacokinetics of cannabidiol in children with refractory epileptic encephalopathy","volume":"62","author":"Guido","year":"2021","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.ejps.2025.107036_bib0102","doi-asserted-by":"crossref","DOI":"10.3399\/bjgpopen20X101010","article-title":"Cannabidiol prescription in clinical practice: an audit on the first 400 patients in New Zealand","volume":"4","author":"Gulbransen","year":"2020","journal-title":"BJGP Open"},{"issue":"2","key":"10.1016\/j.ejps.2025.107036_bib0103","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/ane.13351","article-title":"Cannabidiol in conjunction with clobazam: analysis of four randomized controlled trials","volume":"143","author":"Gunning","year":"2021","journal-title":"Acta Neurol. Scand."},{"issue":"9","key":"10.1016\/j.ejps.2025.107036_bib0104","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1111\/jocd.14352","article-title":"Cannabinoids for skin diseases and hair regrowth","volume":"20","author":"Gupta","year":"2021","journal-title":"J. Cosmet. Dermatol."},{"issue":"6","key":"10.1016\/j.ejps.2025.107036_bib0105","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/ejp.818","article-title":"Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis","volume":"20","author":"Hammell","year":"2016","journal-title":"Eur. J. Pain"},{"issue":"6","key":"10.1016\/j.ejps.2025.107036_bib0106","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/ejp.818","article-title":"Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis","volume":"20","author":"Hammell","year":"2016","journal-title":"Eur. J. Pain"},{"issue":"14","key":"10.1016\/j.ejps.2025.107036_bib0107","doi-asserted-by":"crossref","first-page":"8268","DOI":"10.1073\/pnas.95.14.8268","article-title":"Cannabidiol and (\u2212)\u03949-tetrahydrocannabinol are neuroprotective antioxidants","volume":"95","author":"Hampson","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejps.2025.107036_bib0108","unstructured":"P.D. Hanan Abramovici and P.D. Sophie-Anne Lamour, Ph.D. and G. Mammen, Information for Health Care. 2018."},{"issue":"12","key":"10.1016\/j.ejps.2025.107036_bib0109","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1039\/C6NP00074F","article-title":"Phytocannabinoids: a unified critical inventory","volume":"33","author":"Hanu\u0161","year":"2016","journal-title":"Nat. Prod. Rep."},{"issue":"June","key":"10.1016\/j.ejps.2025.107036_bib0110","article-title":"Advanced multifunctional nano-lipid carrier loaded gel for targeted delivery of 5-flurouracil and cannabidiol against non-melanoma skin cancer","volume":"233","author":"Hasan","year":"2023","journal-title":"Environ. Res."},{"key":"10.1016\/j.ejps.2025.107036_bib0111","unstructured":"\u201cHealth Effects of marijuana and cannabis-derived products presented in new report | National Academies.\u201d https:\/\/www.nationalacademies.org\/news\/2017\/01\/health-effects-of-marijuana-and-cannabis-derived-products-presented-in-new-report (accessed Aug. 27, 2022)."},{"issue":"14","key":"10.1016\/j.ejps.2025.107036_bib0112","doi-asserted-by":"crossref","first-page":"7302","DOI":"10.3390\/ijms22147302","article-title":"Epigenetic regulation of cannabinoid-mediated attenuation of inflammation and its impact on the use of cannabinoids to treat autoimmune diseases","volume":"22","author":"Holloman","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejps.2025.107036_bib0113","unstructured":"home office, \u201cHome Office Circular 2018: rescheduling of cannabis-based products for medicinal use in humans,\u201d 2018, Accessed: Oct. 05, 2022. [Online]. Available: http:\/\/www.legislation.gov.uk\/uksi\/2018\/1055\/contents\/made."},{"issue":"2","key":"10.1016\/j.ejps.2025.107036_bib0114","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ajpath.2011.11.003","article-title":"The endocannabinoid system and plant-derived cannabinoids in diabetes and diabetic complications","volume":"180","author":"Horvth","year":"2012","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.ejps.2025.107036_bib0115","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/pr.54.2.161","article-title":"Classification of cannabinoid receptors","volume":"54","author":"Howlett","year":"2002","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejps.2025.107036_bib0116","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.790803","article-title":"Endocannabinoid system as a promising therapeutic target in inflammatory bowel disease \u2013 A systematic review","volume":"12","author":"Hryhorowicz","year":"2021","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.ejps.2025.107036_bib0117","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1002\/cbdv.200790152","article-title":"Human cannabinoid pharmacokinetics","volume":"4","author":"Huestis","year":"2007","journal-title":"Chem. Biodivers."},{"issue":"10","key":"10.1016\/j.ejps.2025.107036_bib0118","doi-asserted-by":"crossref","first-page":"974","DOI":"10.2174\/1570159X17666190603171901","article-title":"Cannabidiol adverse effects and toxicity","volume":"17","author":"Huestis","year":"2019","journal-title":"Curr. Neuropharmacol."},{"issue":"2","key":"10.1016\/j.ejps.2025.107036_bib0119","article-title":"Cannabis (medical marijuana) treatment for motor and non-motor symptoms of Parkinson disease: an open-label observational study","volume":"37","author":"I","year":"2014","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.ejps.2025.107036_bib0120","unstructured":"\u201cInternational groups re-affirm hemp exempt from global drug rules.\u201d https:\/\/hemptoday.net\/international-groups-re-affirm-hemp-exempt-from-global-drug-rules\/(accessed Aug. 26, 2022)."},{"key":"10.1016\/j.ejps.2025.107036_bib0121","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/bs.apha.2017.04.004","article-title":"Cannabinoid receptor-related orphan G protein-coupled receptors","volume":"80","author":"Irving","year":"2017","journal-title":"Adv. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejps.2025.107036_bib0122","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2133\/dmpk.DMPK-12-RG-129","article-title":"Cannabidiol is a potent inhibitor of the catalytic activity of cytochrome P450 2C19","volume":"28","author":"Jiang","year":"2013","journal-title":"Drug Metab. Pharmacokinet."},{"issue":"4","key":"10.1016\/j.ejps.2025.107036_bib0123","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2133\/dmpk.DMPK-12-RG-129","article-title":"Cannabidiol is a potent inhibitor of the catalytic activity of cytochrome P450 2C19","volume":"28","author":"Jiang","year":"2013","journal-title":"Drug Metab. Pharmacokinet."},{"issue":"5\u20136","key":"10.1016\/j.ejps.2025.107036_bib0124","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.lfs.2011.05.018","article-title":"Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes","volume":"89","author":"Jiang","year":"2011","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.ejps.2025.107036_bib0125","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/0006-2952(79)90358-7","article-title":"The pharmacokinetic fate of cannabidiol and its relationship to barbiturate sleep time","volume":"28","author":"Karler","year":"1979","journal-title":"Biochem. Pharmacol."},{"issue":"18","key":"10.1016\/j.ejps.2025.107036_bib0126","doi-asserted-by":"crossref","first-page":"6740","DOI":"10.3390\/ijms21186740","article-title":"The effects of cannabidiol, a non-intoxicating compound of cannabis, on the cardiovascular system in health and disease","volume":"21","author":"Kicman","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ejps.2025.107036_bib0127","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1080\/13102818.2020.1824620","article-title":"Regulation and marketing of cannabidiol-containing products in European countries. Pharmacists\u2019 knowledge in Bulgaria","volume":"34","author":"Kirilov","year":"2020","journal-title":"Biotechnol. Biotechnol. Equip."},{"issue":"6","key":"10.1016\/j.ejps.2025.107036_bib0128","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3390\/antibiotics9060297","article-title":"Cannabinoids-promising antimicrobial drugs or intoxicants with benefits?","volume":"9","author":"Klahn","year":"2020","journal-title":"Antibiot."},{"issue":"7","key":"10.1016\/j.ejps.2025.107036_bib0129","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1111\/epi.16071","article-title":"Effects of cannabidiol on brivaracetam plasma levels","volume":"60","author":"Klotz","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejps.2025.107036_bib0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.106058","article-title":"Development and pharmacokinetic evaluation of a self-nanoemulsifying drug delivery system for the oral delivery of cannabidiol","volume":"168","author":"Kok","year":"2022","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107036_bib0131","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.fct.2015.03.004","article-title":"Genotoxic properties of representatives of alkylindazoles and aminoalkyl-indoles which are consumed as synthetic cannabinoids","volume":"80","author":"Koller","year":"2015","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ejps.2025.107036_bib0132","unstructured":"E. Kossatz De Mello, D. Patricia, R. Montoya, and R. Maldonado L\u00f3pez, \u201cNeuroprotective mechanisms of CB2 cannabinoid receptors and PPAR-\u03b1 in hypoxia\/ischemia-induced brain damage\u201d."},{"issue":"2","key":"10.1016\/j.ejps.2025.107036_bib0133","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/17425247.2020.1713087","article-title":"Permeation enhancers in transdermal drug delivery: benefits and limitations","volume":"17","author":"Kov\u00e1\u010dik","year":"2020","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejps.2025.107036_bib0134","doi-asserted-by":"crossref","unstructured":"E. Kozela et al., \u201cCannabinoids \u00ce\u201d9-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-\u00ceoB and interferon-\u00ce2\/STAT proinflammatory pathways in BV-2 microglial cells*,\u201d 2009, doi: 10.1074\/jbc.M109.069294.","DOI":"10.1074\/jbc.M109.069294"},{"issue":"1","key":"10.1016\/j.ejps.2025.107036_bib0135","first-page":"1","article-title":"Abnormal cannabidiol attenuates experimental colitis in mice, promotes wound healing and inhibits neutrophil recruitment","volume":"13","author":"Krohn","year":"2016","journal-title":"J. Inflamm. (United Kingdom)"},{"issue":"OCT","key":"10.1016\/j.ejps.2025.107036_bib0136","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3389\/fphar.2016.00361","article-title":"Preclinical and clinical assessment of cannabinoids as anti-cancer agents","volume":"7","author":"Ladin","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejps.2025.107036_bib0137","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3389\/fnins.2016.00323","article-title":"Effects of cannabidiol and hypothermia on short-term brain damage in new-born piglets after acute hypoxia-ischemia","volume":"10","author":"Lafuente","year":"2016","journal-title":"Front. Neurosci."},{"issue":"S1","key":"10.1016\/j.ejps.2025.107036_bib0138","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1684\/epd.2019.1123","article-title":"Pharmacology and drug interactions of cannabinoids","volume":"22","author":"Landmark","year":"2020","journal-title":"Epileptic Disord."},{"issue":"1","key":"10.1016\/j.ejps.2025.107036_bib0139","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1590\/1516-4446-2017-0015","article-title":"Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test","volume":"41","author":"Linares","year":"2019","journal-title":"Rev. Bras. Psiquiatr."},{"issue":"1","key":"10.1016\/j.ejps.2025.107036_bib0140","doi-asserted-by":"crossref","DOI":"10.1186\/s12954-020-00377-0","article-title":"Medical cannabis use in the Australian community following introduction of legal access: the 2018-2019 Online Cross-sectional Cannabis as medicine Survey (CAMS-18)","volume":"17","author":"Lintzeris","year":"2020","journal-title":"Harm. Reduct. J."},{"key":"10.1016\/j.ejps.2025.107036_bib0141","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.pbb.2013.08.013","article-title":"Transdermal delivery of cannabidiol attenuates binge alcohol-induced neurodegeneration in a rodent model of an alcohol use disorder","volume":"111","author":"Liput","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejps.2025.107036_bib0142","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.pbb.2013.08.013","article-title":"Transdermal delivery of cannabidiol attenuates binge alcohol-induced neurodegeneration in a rodent model of an alcohol use disorder","volume":"111","author":"Liput","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.ejps.2025.107036_bib0143","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jconrel.2003.09.001","article-title":"Cannabidiol - transdermal delivery and anti-inflammatory effect in a murine model","volume":"93","author":"Lodzki","year":"2003","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.ejps.2025.107036_bib0144","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jconrel.2003.09.001","article-title":"Cannabidiol\u2014Transdermal delivery and anti-inflammatory effect in a murine model","volume":"93","author":"Lodzki","year":"2003","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/j.ejps.2025.107036_bib0145","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-020-02892-1","article-title":"Cannabidiol (CBD): a killer for inflammatory rheumatoid arthritis synovial fibroblasts","volume":"11","author":"Lowin","year":"2020","journal-title":"Cell Death Dis."},{"issue":"8","key":"10.1016\/j.ejps.2025.107036_bib0146","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-020-02892-1","article-title":"Cannabidiol (CBD): a killer for inflammatory rheumatoid arthritis synovial fibroblasts","volume":"11","author":"Lowin","year":"2020","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.ejps.2025.107036_bib0147","first-page":"607","article-title":"Review of the endocannabinoid system","volume":"6","author":"Lu","year":"2021","journal-title":"Biol. Psychiatry. Cogn. Neurosci. Neuroimaging"},{"issue":"6","key":"10.1016\/j.ejps.2025.107036_bib0148","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-3256","article-title":"Clinically significant drug-drug interaction between methadone and cannabidiol","volume":"145","author":"Madden","year":"2020","journal-title":"Pediatrics"},{"issue":"12","key":"10.1016\/j.ejps.2025.107036_bib0149","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.36849\/JDD.2020.5464","article-title":"An observational study of the application of a topical cannabinoid gel on sensitive dry skin","volume":"19","author":"Maghfour","year":"2020","journal-title":"J. Drugs Dermatol."},{"issue":"12","key":"10.1016\/j.ejps.2025.107036_bib0150","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.36849\/JDD.2020.5464","article-title":"An observational study of the application of a topical cannabinoid gel on sensitive dry skin","volume":"19","author":"Maghfour","year":"2020","journal-title":"J. Drugs Dermatol."},{"issue":"8","key":"10.1016\/j.ejps.2025.107036_bib0151","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1111\/ced.14749","article-title":"Tolerability profile of topical cannabidiol and palmitoylethanolamide: a compilation of single-centre randomized evaluator-blinded clinical and in vitro studies in normal skin","volume":"46","author":"Maghfour","year":"2021","journal-title":"Clin. Exp. Dermatol."},{"issue":"5","key":"10.1016\/j.ejps.2025.107036_bib0152","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.jpainsymman.2017.06.005","article-title":"Topical medical cannabis: A new treatment for wound pain\u2014Three cases of Pyoderma gangrenosum","volume":"54","author":"Maida","year":"2017","journal-title":"J. Pain Symptom. Manage."},{"issue":"1","key":"10.1016\/j.ejps.2025.107036_bib0153","article-title":"Topical cannabidiol (CBD) in skin pathology \u2013 A comprehensive review and prospects for new therapeutic opportunities","volume":"64","author":"Makhakhe","year":"2022","journal-title":"South Afr. Fam. Pract."},{"issue":"3","key":"10.1016\/j.ejps.2025.107036_bib0154","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/ADM.0000000000000118","article-title":"Safety and pharmacokinetics of oral cannabidiol when administered concomitantly with intravenous Fentanyl in humans","volume":"9","author":"Manini","year":"2015","journal-title":"J. Addict. Med."},{"issue":"6","key":"10.1016\/j.ejps.2025.107036_bib0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biom10060900","article-title":"Isolation, purification, and antimicrobial characterization of cannabidiolic acid and cannabidiol from cannabis sativa L","volume":"10","author":"Martinenghi","year":"2020","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.ejps.2025.107036_bib0156","doi-asserted-by":"crossref","DOI":"10.3390\/ph15020210","article-title":"Cannabis-based products for the treatment of skin inflammatory diseases: A timely review","volume":"15","author":"Martins","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"issue":"32","key":"10.1016\/j.ejps.2025.107036_bib0157","doi-asserted-by":"crossref","first-page":"4966","DOI":"10.2174\/138161212802884780","article-title":"Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers","volume":"18","author":"Martin-Santos","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejps.2025.107036_bib0158","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/8143582","article-title":"An assessment of the genotoxicity and subchronic toxicity of a supercritical fluid extract of the aerial parts of hemp","volume":"2018","author":"Marx","year":"2018","journal-title":"J. Toxicol."},{"key":"10.1016\/j.ejps.2025.107036_bib0159","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.3389\/fpsyg.2019.02466","article-title":"Anxiolytic effects of repeated cannabidiol treatment in teenagers with social anxiety disorders","volume":"10","author":"Masataka","year":"2019","journal-title":"Front. Psychol."},{"issue":"2","key":"10.1016\/j.ejps.2025.107036_bib0160","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2125.2012.04298.x","article-title":"Cannabidiol as potential anticancer drug","volume":"75","author":"Massi","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2025.107036_bib0161","doi-asserted-by":"crossref","first-page":"l574","DOI":"10.1136\/bmj.l574","article-title":"WHO proposes rescheduling cannabis to allow medical applications","volume":"364","author":"Mayor","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.ejps.2025.107036_bib0162","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102935","article-title":"Access to cannabidiol without a prescription: A cross-country comparison and analysis","volume":"85","author":"McGregor","year":"2020","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.ejps.2025.107036_bib0163","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pharmthera.2016.06.011","article-title":"Microglia activation states and cannabinoid system: therapeutic implications","volume":"166","author":"Mecha","year":"2016","journal-title":"Pharmacol. Ther."},{"issue":"S1","key":"10.1016\/j.ejps.2025.107036_bib0164","doi-asserted-by":"crossref","first-page":"11S","DOI":"10.1002\/j.1552-4604.2002.tb05998.x","article-title":"Cannabidiol: an overview of some pharmacological aspects","volume":"42","author":"Mechoulam","year":"2002","journal-title":"J. Clin. Pharmacol."},{"issue":"8","key":"10.1016\/j.ejps.2025.107036_bib0165","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/cbdv.200790147","article-title":"Cannabidiol \u2013 Recent advances","volume":"4","author":"Mechoulam","year":"2007","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.ejps.2025.107036_bib0166","unstructured":"\u201cMedical Cannabis Access Programme launch enables compassionate access to cannabis for medical reasons - MerrionStreet.\u201d https:\/\/merrionstreet.ie\/en\/news-room\/releases\/medical_cannabis_access_programme_launch_enables_compassionate_access_to_cannabis_for_medical_reasons.html (accessed Jan. 19, 2023)."},{"issue":"1","key":"10.1016\/j.ejps.2025.107036_bib0167","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1089\/can.2015.0004","article-title":"Identification of psychoactive degradants of cannabidiol in simulated gastric and physiological fluid","volume":"1","author":"Merrick","year":"2016","journal-title":"Cannabis Cannabinoid Res."},{"issue":"9","key":"10.1016\/j.ejps.2025.107036_bib0168","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3390\/ph13090219","article-title":"Towards better delivery of cannabidiol (CBD)","volume":"13","author":"Millar","year":"2020","journal-title":"Pharmaceuticals"},{"issue":"9","key":"10.1016\/j.ejps.2025.107036_bib0169","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ph13090219","article-title":"Towards better delivery of cannabidiol (Cbd)","volume":"13","author":"Millar","year":"2020","journal-title":"Pharmaceuticals"},{"issue":"9","key":"10.1016\/j.ejps.2025.107036_bib0170","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1111\/bcp.14038","article-title":"A systematic review of cannabidiol dosing in clinical populations","volume":"85","author":"Millar","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"NOV","key":"10.1016\/j.ejps.2025.107036_bib0171","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.3389\/fphar.2018.01365","article-title":"A systematic review on the pharmacokinetics of cannabidiol in humans","volume":"9","author":"Millar","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"22","key":"10.1016\/j.ejps.2025.107036_bib0172","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21228870","article-title":"Cannabidiol for Pain treatment: focus on pharmacology and mechanism of action","volume":"21","author":"Mlost","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.ejps.2025.107036_bib0173","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3390\/ijms22020833","article-title":"A review of plant extracts and plant-derived natural compounds in the prevention\/treatment of neonatal hypoxic-ischemic brain injury","volume":"22","author":"Mohsenpour","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.ejps.2025.107036_bib0174","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15020537","article-title":"Cannabidiol-loaded nanostructured lipid carriers (NLCs) for dermal delivery: enhancement of photostability, cell viability, and anti-inflammatory activity","volume":"15","author":"Morakul","year":"2023","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.ejps.2025.107036_bib0175","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.msard.2015.08.001","article-title":"The disease-modifying effects of a Sativex-like combination of phytocannabinoids in mice with experimental autoimmune encephalomyelitis are preferentially due to \u03949-tetrahydrocannabinol acting through CB1 receptors","volume":"4","author":"Moreno-Martet","year":"2015","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.ejps.2025.107036_bib0176","unstructured":"\u201cMorocco pardons 4,800 jailed for cultivating cannabis - so they can farm legally | Middle East Eye.\u201d https:\/\/www.middleeasteye.net\/news\/morocco-pardons-more-4800-cannabis-farming-offenders?utm_source=chatgpt.com (accessed Jan. 17, 2025)."},{"issue":"8","key":"10.1016\/j.ejps.2025.107036_bib0177","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/cpdd.665","article-title":"A phase 1, open-label, pharmacokinetic trial to investigate possible drug-drug interactions between Clobazam, Stiripentol, or valproate and cannabidiol in healthy subjects","volume":"8","author":"Morrison","year":"2019","journal-title":"Clin. Pharmacol. Drug Dev."},{"issue":"2","key":"10.1016\/j.ejps.2025.107036_bib0178","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0939-6411(01)00166-7","article-title":"Passive skin penetration enhancement and its quantification in vitro","volume":"52","author":"Moser","year":"2001","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2025.107036_bib0179","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2023.102664","article-title":"Evaluation of cannabidiol nanoparticles and nanoemulsion biodistribution in the central nervous system after intrathecal administration for the treatment of pain","volume":"49","author":"Muresan","year":"2023","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"6","key":"10.1016\/j.ejps.2025.107036_bib0180","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/01.ftd.0000177223.19294.5c","article-title":"Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of Delta9-tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extract","volume":"27","author":"Nadulski","year":"2005","journal-title":"Ther. Drug Monit."},{"issue":"8","key":"10.1016\/j.ejps.2025.107036_bib0181","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1093\/jat\/29.8.782","article-title":"Simultaneous and sensitive analysis of THC, 11-OH-THC, THC-COOH, CBD, and CBN by GC\u2013MS in plasma after oral application of small doses of THC and cannabis extract","volume":"29","author":"Nadulski","year":"2005","journal-title":"J. Anal. Toxicol."},{"issue":"7","key":"10.1016\/j.ejps.2025.107036_bib0182","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.4155\/fmc.09.93","article-title":"Cannabinoids as novel anti-inflammatory drugs","volume":"1","author":"Nagarkatti","year":"2009","journal-title":"Future Med. Chem."},{"issue":"1","key":"10.1016\/j.ejps.2025.107036_bib0183","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1089\/can.2017.0009","article-title":"A conversion of oral cannabidiol to Delta9-tetrahydrocannabinol seems not to occur in humans","volume":"2","author":"Nahler","year":"2017","journal-title":"Cannabis Cannabinoid Res."},{"issue":"1","key":"10.1016\/j.ejps.2025.107036_bib0184","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000497361","article-title":"Development of a novel nano-emulsion formulation to improve intestinal absorption of cannabidiol","volume":"2","author":"Nakano","year":"2019","journal-title":"Med. Cannabis Cannabinoids"},{"issue":"12","key":"10.1016\/j.ejps.2025.107036_bib0185","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1124\/dmd.121.000442","article-title":"Cannabinoid metabolites as inhibitors of major hepatic CYP450 enzymes, with implications for cannabis-drug interactions","volume":"49","author":"Nasrin","year":"2021","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2025.107036_bib0186","first-page":"1","article-title":"NTP toxicology and carcinogenesis studies of 1-trans-delta(9)-tetrahydrocannabinol (CAS No. 1972-08-3) in F344 rats and B6C3F1 mice (Gavage Studies)","volume":"446","year":"1996","journal-title":"Natl. Toxicol. Program Tech. Rep. Ser."},{"issue":"21","key":"10.1016\/j.ejps.2025.107036_bib0187","doi-asserted-by":"crossref","first-page":"12137","DOI":"10.1021\/acs.jmedchem.0c00724","article-title":"The essential medicinal chemistry of cannabidiol (CBD)","volume":"63","author":"Nelson","year":"2020","journal-title":"J. Med. Chem."},{"issue":"21","key":"10.1016\/j.ejps.2025.107036_bib0188","doi-asserted-by":"crossref","first-page":"12137","DOI":"10.1021\/acs.jmedchem.0c00724","article-title":"The essential medicinal chemistry of cannabidiol (CBD)","volume":"63","author":"Nelson","year":"2020","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejps.2025.107036_bib0189","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1089\/can.2018.0073","article-title":"Immune responses regulated by cannabidiol","volume":"5","author":"Nichols","year":"2020","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.ejps.2025.107036_bib0190","unstructured":"L.A.W. No, \u201cLAW No . 50-88 [OF 30 MAY 1988] On Drugs and Controlled Substances in the Dominican Republic In the name of the Republic,\u201d no. 50, 1988."},{"issue":"7","key":"10.1016\/j.ejps.2025.107036_bib0191","doi-asserted-by":"crossref","first-page":"393","DOI":"10.14740\/jocmr4159","article-title":"The impact of cannabidiol on psychiatric and medical conditions","volume":"12","author":"Oberbarnscheidt","year":"2020","journal-title":"J. Clin. Med. Res."},{"issue":"9","key":"10.1016\/j.ejps.2025.107036_bib0192","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1172\/JCI64628","article-title":"Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes","volume":"124","author":"Ol\u00e1h","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.ejps.2025.107036_bib0193","article-title":"Open label evaluation of cannabidiol in dystonic movement disorders","volume":"30","author":"P","year":"1986","journal-title":"Int. J. Neurosci."},{"issue":"5","key":"10.1016\/j.ejps.2025.107036_bib0194","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1515\/cclm-2019-0119","article-title":"THC and CBD concentrations in blood, oral fluid and urine following a single and repeated administration of \u2018light cannabis","volume":"58","author":"Pacifici","year":"2020","journal-title":"Clin. Chem. Lab. Med."},{"issue":"2","key":"10.1016\/j.ejps.2025.107036_bib0195","first-page":"E93","article-title":"A therapeutic effect of cbd-enriched ointment in inflammatory skin diseases and cutaneous scars","volume":"170","author":"Palmieri","year":"2019","journal-title":"Clin. Ter."},{"issue":"2","key":"10.1016\/j.ejps.2025.107036_bib0196","first-page":"e93","article-title":"A therapeutic effect of cbd-enriched ointment in inflammatory skin diseases and cutaneous scars","volume":"170","author":"Palmieri","year":"2019","journal-title":"Clin. Ter."},{"issue":"2","key":"10.1016\/j.ejps.2025.107036_bib0197","article-title":"The effect of cannabinoids on wound healing: A review","volume":"7","author":"Parikh","year":"2024","journal-title":"Heal. Sci. Reports"},{"issue":"7","key":"10.1016\/j.ejps.2025.107036_bib0198","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1111\/j.1476-5381.2010.01176.x","article-title":"Regulation of nausea and vomiting by cannabinoids","volume":"163","author":"Parker","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejps.2025.107036_bib0199","unstructured":"C. Partalis, \u201cDevelopment of silica nanoparticle transdermal delivery systems for cannabidiol,\u201d no. February, 2022, [Online]. Available: \/articles\/thesis\/Development_of_silica_nanoparticle_transdermal_delivery_systems_for_cannabidiol\/21555219\/1."},{"issue":"9","key":"10.1016\/j.ejps.2025.107036_bib0200","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3109\/03639041003657295","article-title":"Cannabidiol bioavailability after nasal and transdermal application: effect of permeation enhancers","volume":"36","author":"Paudel","year":"2010","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"5","key":"10.1016\/j.ejps.2025.107036_bib0201","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.3390\/molecules23051230","article-title":"Quality traits of \u2018cannabidiol oils\u2019: cannabinoids content, terpene fingerprint and oxidation stability of European commercially available preparations","volume":"23","author":"Pavlovic","year":"2018","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.ejps.2025.107036_bib0202","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.neuropharm.2012.05.034","article-title":"Cannabidiol administration after hypoxia-ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function","volume":"63","author":"Pazos","year":"2012","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.ejps.2025.107036_bib0203","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27020491","article-title":"In vitro and clinical evaluation of cannabigerol (CBG) produced via yeast biosynthesis: A cannabinoid with a broad range of anti-inflammatory and skin health-boosting properties","volume":"27","author":"Perez","year":"2022","journal-title":"Molecules"},{"issue":"12","key":"10.1016\/j.ejps.2025.107036_bib0204","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ph13120459","article-title":"Disposition of cannabidiol metabolites in serum and urine from healthy individuals treated with pharmaceutical preparations of medical cannabis","volume":"13","author":"P\u00e9rez-Acevedo","year":"2020","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.ejps.2025.107036_bib0205","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2147\/ITT.S263690","article-title":"Cannabidiol as a novel therapeutic for immune modulation","volume":"9","author":"Peyravian","year":"2020","journal-title":"ImmunoTargets Ther."},{"key":"10.1016\/j.ejps.2025.107036_bib0206","unstructured":"\u201cPL-x nr. 631\/2019.\u201d http:\/\/www.cdep.ro\/pls\/proiecte\/upl_pck2015.proiect?idp=18223 (accessed Oct. 05, 2022)."},{"issue":"12","key":"10.1016\/j.ejps.2025.107036_bib0207","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci11121573","article-title":"The neuroprotective effects of cannabis-derived phytocannabinoids and resveratrol in Parkinson's Disease: A systematic literature review of pre-clinical studies","volume":"11","author":"Prakash","year":"2021","journal-title":"Brain Sci."},{"key":"10.1016\/j.ejps.2025.107036_bib0208","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2019.108914","article-title":"The influence of carboxylesterase 1 polymorphism and cannabidiol on the hepatic metabolism of heroin","volume":"316","author":"Qian","year":"2020","journal-title":"Chem. Biol. Interact."},{"issue":"5","key":"10.1016\/j.ejps.2025.107036_bib0209","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/JCP.0000000000001089","article-title":"The potential for pharmacokinetic interactions between cannabis products and conventional medications","volume":"39","author":"Qian","year":"2019","journal-title":"J. Clin. Psychopharmacol."},{"issue":"25","key":"10.1016\/j.ejps.2025.107036_bib0210","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/j.jacc.2010.07.033","article-title":"Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, inflammatory and cell death signaling pathways in diabetic cardiomyopathy","volume":"56","author":"Rajesh","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"issue":"Suppl 1","key":"10.1016\/j.ejps.2025.107036_bib0211","article-title":"Current state of cannabis use, policies, and research across sixteen countries: cross-country comparisons and international perspectives","volume":"44","author":"Ransing","year":"2022","journal-title":"Trends Psychiatry Psychother"},{"key":"10.1016\/j.ejps.2025.107036_bib0212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.partic.2021.11.010","article-title":"Enhanced bioavailability and biosafety of cannabidiol nanomicelles for effective anti-inflammatory therapy","volume":"69","author":"Rao","year":"2022","journal-title":"Particuology"},{"issue":"1","key":"10.1016\/j.ejps.2025.107036_bib0213","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1476-5381.2008.00046.x","article-title":"5-HT 1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats","volume":"156","author":"Resstel","year":"2009","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.ejps.2025.107036_bib0214","doi-asserted-by":"crossref","DOI":"10.1007\/s11910-018-0859-x","article-title":"Cannabinoids for treatment of MS symptoms: State of the evidence","volume":"18","author":"Rice","year":"2018","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"7","key":"10.1016\/j.ejps.2025.107036_bib0215","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/j.1476-5381.2008.00107.x","article-title":"Synthetic and plant-derived cannabinoid receptor antagonists show hypophagic properties in fasted and non-fasted mice","volume":"156","author":"Riedel","year":"2009","journal-title":"Br. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.ejps.2025.107036_bib0216","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1016\/j.jid.2017.05.035","article-title":"Cannabinoid reduces inflammatory cytokines tumor necrosis factor alpha and type I interferons in dermatomyositis in vitro","volume":"137","author":"Robinson","year":"2017","journal-title":"J. Invest. Dermatol."},{"issue":"3","key":"10.1016\/j.ejps.2025.107036_bib0217","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/bph.12316","article-title":"Tetrahydrocannabinolic acid reduces nausea-induced conditioned gaping in rats and vomiting in Suncus murinus","volume":"170","author":"Rock","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejps.2025.107036_bib0218","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.pbb.2013.08.012","article-title":"Suppression of lithium chloride-induced conditioned gaping (a model of nausea-induced behaviour) in rats (using the taste reactivity test) with metoclopramide is enhanced by cannabidiolic acid","volume":"111","author":"Rock","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.ejps.2025.107036_bib0219","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/bph.12162","article-title":"Effect of low doses of cannabidiolic acid and ondansetron on LiCl-induced conditioned gaping (a model of nausea-induced behaviour) in rats","volume":"169","author":"Rock","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"JUL","key":"10.1016\/j.ejps.2025.107036_bib0220","first-page":"221","article-title":"Cannabinoids as potential treatment for chemotherapy-induced nausea and vomiting","volume":"7","author":"Rock","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejps.2025.107036_bib0221","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104749","article-title":"Cannabidiol attenuates behavioral changes in a rodent model of schizophrenia through 5-HT1A, but not CB1 and CB2 receptors","volume":"156","author":"Rodrigues da Silva","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.ejps.2025.107036_bib0222","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/0041-008X(81)90122-8","article-title":"Toxicity of short-term administration of cannabinoids to rhesus monkeys","volume":"58","author":"Rosenkrantz","year":"1981","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejps.2025.107036_bib0223","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00204-018-2322-9","article-title":"Low doses of widely consumed cannabinoids (cannabidiol and cannabidivarin) cause DNA damage and chromosomal aberrations in human-derived cells","volume":"93","author":"Russo","year":"2019","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.ejps.2025.107036_bib0224","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.3389\/fpls.2018.01969","article-title":"The case for the entourage effect and conventional breeding of clinical cannabis: No \u2018strain,\u2019 no gain","volume":"9","author":"Russo","year":"2019","journal-title":"Front. Plant Sci."},{"key":"10.1016\/j.ejps.2025.107036_bib0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122016","article-title":"Enhancement of transdermal permeation of cannabinoids and their pharmacodynamic evaluation in rats","volume":"624","author":"Salau","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107036_bib0226","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-981-10-7757-9_6","article-title":"Transient receptor potential (TRP) channels","volume":"87","author":"Samanta","year":"2018","journal-title":"Subcell. Biochem."},{"issue":"8","key":"10.1016\/j.ejps.2025.107036_bib0227","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1002\/ptr.6400","article-title":"Cannabis sativa L. extract and cannabidiol inhibit in vitro mediators of skin inflammation and wound injury","volume":"33","author":"Sangiovanni","year":"2019","journal-title":"Phyther. Res."},{"issue":"8","key":"10.1016\/j.ejps.2025.107036_bib0228","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1002\/ptr.6400","article-title":"Cannabis sativa L. extract and cannabidiol inhibit in vitro mediators of skin inflammation and wound injury","volume":"33","author":"Sangiovanni","year":"2019","journal-title":"Phytother. Res."},{"key":"10.1016\/j.ejps.2025.107036_bib0229","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2019.00094","article-title":"Prolonged cannabidiol treatment lacks on detrimental effects on memory, motor performance and anxiety in C57BL\/6J mice","volume":"13","author":"Schleicher","year":"2019","journal-title":"Front. Behav. Neurosci."},{"issue":"11","key":"10.1016\/j.ejps.2025.107036_bib0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers12113203","article-title":"Cannabidiol (CBD) as a promising anti-cancer drug","volume":"12","author":"Seltzer","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejps.2025.107036_bib0231","first-page":"305","article-title":"International Drug Control Conventions","author":"Shelley","year":"2013","journal-title":"United Nations Off. Drugs Crime"},{"issue":"8","key":"10.1016\/j.ejps.2025.107036_bib0232","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1080\/09546634.2019.1675854","article-title":"The potential role of cannabinoids in dermatology","volume":"31","author":"Sheriff","year":"2020","journal-title":"J. Dermatol. Treat."},{"issue":"1","key":"10.1016\/j.ejps.2025.107036_bib0233","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40824-023-00390-x","article-title":"Effervescent cannabidiol solid dispersion-doped dissolving microneedles for boosted melanoma therapy via the \u2018TRPV1-NFATc1-ATF3\u2019 pathway and tumor microenvironment engineering","volume":"27","author":"Shi","year":"2023","journal-title":"Biomater. Res."},{"issue":"0","key":"10.1016\/j.ejps.2025.107036_bib0234","first-page":"1","article-title":"CFD simulation of cannabidiol delivery through microneedle patches","volume":"0","author":"Shi","year":"2024","journal-title":"Comput. Methods Biomech. Biomed. Engin."},{"issue":"5","key":"10.1016\/j.ejps.2025.107036_bib0235","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/jat\/bkab059","article-title":"Urinary pharmacokinetic profile of cannabidiol (CBD), \u03949-tetrahydrocannabinol (THC) and their metabolites following oral and vaporized CBD and vaporized CBD-dominant Cannabis administration","volume":"46","author":"Sholler","year":"2021","journal-title":"J. Anal. Toxicol."},{"issue":"6","key":"10.1016\/j.ejps.2025.107036_bib0236","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00403-015-1572-0","article-title":"A comprehensive evidence-based review on the role of topicals and dressings in the management of skin scarring","volume":"307","author":"Sidgwick","year":"2015","journal-title":"Arch. Dermatol. Res."},{"issue":"12","key":"10.1016\/j.ejps.2025.107036_bib0237","first-page":"1269","article-title":"Strain-, sex-, and time-dependent antidepressant-like effects of cannabidiol","volume":"14","author":"Silote","year":"2021","journal-title":"Pharm"},{"issue":"1","key":"10.1016\/j.ejps.2025.107036_bib0238","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/1471-0528.15946","article-title":"Prevalence and outcomes of prenatal recreational cannabis use in high-income countries: a scoping review","volume":"127","author":"Singh","year":"2020","journal-title":"BJOG Int. J. Obstet. Gynaecol."},{"issue":"19","key":"10.1016\/j.ejps.2025.107036_bib0239","doi-asserted-by":"crossref","first-page":"6067","DOI":"10.1021\/jacs.7b11281","article-title":"Selective photoaffinity probe that enables assessment of cannabinoid CB2 receptor expression and ligand engagement in Human cells","volume":"140","author":"Soethoudt","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejps.2025.107036_bib0240","article-title":"Cannabidiol and cancer \u2014 An overview of the preclinical data","author":"Solinas","year":"2015","journal-title":"Mol. Consider. Evol. Surg. Manag. Issues Treat. Patients Brain Tumor"},{"issue":"2","key":"10.1016\/j.ejps.2025.107036_bib0241","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1365-2125.2012.04351.x","article-title":"Is the cardiovascular system a therapeutic target for cannabidiol?","volume":"75","author":"Stanley","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"20","key":"10.1016\/j.ejps.2025.107036_bib0242","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1021\/acschemneuro.2c00502","article-title":"Identification of CB1 ligands among drugs, phytochemicals and natural-like compounds: virtual screening and In vitro verification","volume":"13","author":"Stasiulewicz","year":"2022","journal-title":"ACS Chem. Neurosci."},{"issue":"13","key":"10.1016\/j.ejps.2025.107036_bib0243","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s40265-021-01579-x","article-title":"Cannabinoid formulations and delivery systems: current and future options to treat pain","volume":"81","author":"Stella","year":"2021","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.ejps.2025.107036_bib0244","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2193-1801-2-236","article-title":"A phase I, open-label, randomized, crossover study in three parallel groups to evaluate the effect of rifampicin, ketoconazole, and omeprazole on the pharmacokinetics of THC\/CBD oromucosal spray in healthy volunteers","volume":"2","author":"Stott","year":"2013","journal-title":"Springerplus"},{"key":"10.1016\/j.ejps.2025.107036_bib0245","unstructured":"T. St\u00f6ver, H., Michels, I.I., Werse,& B., Pfeiffer-Gerschel, \u201cCannabis regulation in Europe: country report German,\u201d 2019. Accessed: Oct. 05, 2022. [Online]. Available: https:\/\/www.tni.org\/files\/publication-downloads\/cr_ned_def.pdf."},{"key":"10.1016\/j.ejps.2025.107036_bib0246","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.3389\/fimmu.2020.613613","article-title":"Cannabinoids as key regulators of inflammasome signaling: A current perspective","volume":"11","author":"Suryavanshi","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejps.2025.107036_bib0247","unstructured":"\u201cThe Death Penalty for Drug Offences: Global Overview 2023 - Harm Reduction International.\u201d https:\/\/hri.global\/flagship-research\/death-penalty\/the-death-penalty-for-drug-offences-global-overview-2023\/(accessed Jan. 16, 2025)."},{"key":"10.1016\/j.ejps.2025.107036_bib0248","unstructured":"\u201cThe Germany Cannabis Report | Cannabis Markets | Prohibition Partners.\u201d https:\/\/prohibitionpartners.com\/reports\/the-germany-cannabis-report\/(accessed Oct. 05, 2022)."},{"issue":"1","key":"10.1016\/j.ejps.2025.107036_bib0249","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s42238-024-00229-9","article-title":"Envisaging challenges for the emerging medicinal cannabis sector in Lesotho","volume":"6","author":"Thetsane","year":"2024","journal-title":"J. Cannabis Res."},{"issue":"10125","key":"10.1016\/j.ejps.2025.107036_bib0250","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(18)30136-3","article-title":"Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"391","author":"Thiele","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ejps.2025.107036_bib0251","unstructured":"G. Thota, \u201cCannabidiol coated 3D printed microneedles for transdermal diffusion,\u201d pp. 3\u20134, 2019."},{"key":"10.1016\/j.ejps.2025.107036_bib0252","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jconrel.2021.05.005","article-title":"Delivering therapeutic cannabinoids via skin: current state and future perspectives","volume":"334","author":"Tijani","year":"2021","journal-title":"J. Control. Release"},{"issue":"7","key":"10.1016\/j.ejps.2025.107036_bib0253","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.3390\/cancers12071985","article-title":"Anti-cancer potential of cannabinoids, terpenes, and flavonoids present in cannabis","volume":"12","author":"Tomko","year":"2020","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.ejps.2025.107036_bib0254","doi-asserted-by":"crossref","first-page":"918","DOI":"10.3390\/molecules24050918","article-title":"Cannabinoid signaling in the skin: therapeutic potential of the \u2018C(ut)annabinoid\u2019 system","volume":"24","author":"T\u00f3th","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejps.2025.107036_bib0255","unstructured":"D. Trial, P. Olczyk, O. Batoryna, W. Kempa, and K. Walczy, \u201cMyorelaxant E ff ect of transdermal cannabidiol application in patients with TMD: A randomized,\u201d."},{"issue":"6","key":"10.1016\/j.ejps.2025.107036_bib0256","article-title":"Statement on safety of cannabidiol as a novel food: data gaps and uncertainties","volume":"20","author":"Turck","year":"2022","journal-title":"EFSA J."},{"key":"10.1016\/j.ejps.2025.107036_bib0257","unstructured":"\u201cU.S. Food and Drug Administration.\u201d https:\/\/www.fda.gov\/."},{"issue":"1","key":"10.1016\/j.ejps.2025.107036_bib0258","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1089\/can.2015.0012","article-title":"Human metabolites of cannabidiol: A review on their formation, biological activity, and relevance in therapy","volume":"1","author":"Ujv\u00e1ry","year":"2016","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.ejps.2025.107036_bib0259","unstructured":"\u201cUN Commission on Narcotic Drugs reclassifies cannabis to recognize its therapeutic uses.\u201d https:\/\/www.who.int\/news\/item\/04-12-2020-un-commission-on-narcotic-drugs-reclassifies-cannabis-to-recognize-its-therapeutic-uses (accessed Aug. 27, 2022)."},{"issue":"3","key":"10.1016\/j.ejps.2025.107036_bib0260","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.bpa.2020.06.004","article-title":"Use of cannabidiol (CBD) for the treatment of chronic pain","volume":"34","author":"Urits","year":"2020","journal-title":"Best Pract. Res. Clin. Anaesthesiol."},{"issue":"1","key":"10.1016\/j.ejps.2025.107036_bib0261","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s13311-014-0304-z","article-title":"Neuroprotective properties of cannabigerol in Huntington's Disease: studies in R6\/2 mice and 3-nitropropionate-lesioned mice","volume":"12","author":"Valdeolivas","year":"2015","journal-title":"Neurotherapeutics"},{"issue":"4","key":"10.1016\/j.ejps.2025.107036_bib0262","doi-asserted-by":"crossref","first-page":"684","DOI":"10.3390\/ijms18040684","article-title":"Effects of a sativex-like combination of phytocannabinoids on disease progression in R6\/2 mice, an experimental model of Huntington's disease","volume":"18","author":"Valdeolivas","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.ejps.2025.107036_bib0263","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1002\/jcph.1634","article-title":"A phase 2, double-blind, placebo-controlled trial to investigate potential drug-drug interactions between cannabidiol and clobazam","volume":"60","author":"VanLandingham","year":"2020","journal-title":"J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejps.2025.107036_bib0264","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s12325-022-02345-5","article-title":"Examining the systemic bioavailability of cannabidiol and tetrahydrocannabinol from a novel transdermal delivery system in healthy adults: A single-arm, open-label, exploratory study","volume":"40","author":"Varadi","year":"2023","journal-title":"Adv. Ther."},{"issue":"1","key":"10.1016\/j.ejps.2025.107036_bib0265","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s12325-022-02345-5","article-title":"Examining the systemic bioavailability of cannabidiol and tetrahydrocannabinol from a novel transdermal delivery system in healthy adults: A single-arm, open-label, exploratory study","volume":"40","author":"Varadi","year":"2023","journal-title":"Adv. Ther."},{"key":"10.1016\/j.ejps.2025.107036_bib0266","series-title":"Advances in Experimental Medicine and Biology","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-3-030-61663-2_3","article-title":"Clinical pharmacokinetics of cannabinoids and potential drug-drug interactions","author":"V\u00e1zquez","year":"2021"},{"issue":"6","key":"10.1016\/j.ejps.2025.107036_bib0267","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1159\/000510896","article-title":"Efficacy and tolerability of a shampoo containing broad-spectrum cannabidiol in the treatment of scalp inflammation in patients with mild to moderate scalp psoriasis or seborrheic dermatitis","volume":"6","author":"Vincenzi","year":"2020","journal-title":"Ski. Appendage Disord."},{"key":"10.1016\/j.ejps.2025.107036_bib0268","unstructured":"\u201cWalgreens to sell CBD products in 1,500 stores.\u201d https:\/\/www.cnbc.com\/2019\/03\/27\/walgreens-to-sell-cbd-products-in-some-stores.html (accessed Jan. 19, 2023)."},{"issue":"S1","key":"10.1016\/j.ejps.2025.107036_bib0269","doi-asserted-by":"crossref","first-page":"178S","DOI":"10.1002\/j.1552-4604.1981.tb02594.x","article-title":"The metabolism of \u03949-tetrahydrocannabinol and related cannabinoids in man","volume":"21","author":"Wall","year":"1981","journal-title":"J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.ejps.2025.107036_bib0270","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1111\/j.1476-5381.2010.00755.x","article-title":"Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion","volume":"160","author":"Walsh","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejps.2025.107036_bib0271","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1089\/can.2016.0020","article-title":"Decarboxylation study of acidic cannabinoids: A novel approach using ultra-high-performance supercritical fluid chromatography\/photodiode array-mass spectrometry","volume":"1","author":"Wang","year":"2016","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.ejps.2025.107036_bib0272","unstructured":"\u201cWarning Letters and Test Results for cannabidiol-related products | FDA.\u201d https:\/\/www.fda.gov\/news-events\/public-health-focus\/warning-letters-and-test-results-cannabidiol-related-products (accessed Oct. 05, 2022)."},{"issue":"1","key":"10.1016\/j.ejps.2025.107036_bib0273","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-60952-0","article-title":"Cannabidiol is an effective helper compound in combination with bacitracin to kill gram-positive bacteria","volume":"10","author":"Wassmann","year":"2020","journal-title":"Sci. Rep."},{"issue":"6947","key":"10.1016\/j.ejps.2025.107036_bib0274","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/nature01807","article-title":"Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels","volume":"424","author":"Watanabe","year":"2003","journal-title":"Nature"},{"issue":"June","key":"10.1016\/j.ejps.2025.107036_bib0275","first-page":"4","article-title":"Cannabidiol (CBD) Critical Review Report","year":"2018","journal-title":"Expert. Comm. Drug Depend."},{"issue":"1","key":"10.1016\/j.ejps.2025.107036_bib0276","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ph14010035","article-title":"Comparison of five oral cannabidiol preparations in adult humans: pharmacokinetics, body composition, and heart rate variability","volume":"14","author":"Williams","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"18","key":"10.1016\/j.ejps.2025.107036_bib0277","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21186795","article-title":"Cannabidiol modifies the formation of NETs in neutrophils of psoriatic patients","volume":"21","author":"W\u00f3jcik","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.ejps.2025.107036_bib0278","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1084\/jem.20120242","article-title":"Cannabinoids suppress inflammatory and neuropathic pain by targeting \u03b13 glycine receptors","volume":"209","author":"Xiong","year":"2012","journal-title":"J. Exp. Med."},{"issue":"9","key":"10.1016\/j.ejps.2025.107036_bib0279","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci11091211","article-title":"Understanding the modulatory effects of cannabidiol on Alzheimer's disease","volume":"11","author":"Xiong","year":"2021","journal-title":"Brain Sci."},{"key":"10.1016\/j.ejps.2025.107036_bib0280","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.lfs.2015.07.007","article-title":"Cannabidiol induces expression of human cytochrome P450 1A1 that is possibly mediated through aryl hydrocarbon receptor signaling in HepG2 cells","volume":"136","author":"Yamaori","year":"2015","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.ejps.2025.107036_bib0281","doi-asserted-by":"crossref","first-page":"294","DOI":"10.2133\/dmpk.DMPK-11-RG-107","article-title":"Comparison in the in vitro inhibitory effects of major phytocannabinoids and polycyclic aromatic hydrocarbons contained in marijuana smoke on cytochrome P450 2C9 activity","volume":"27","author":"Yamaori","year":"2012","journal-title":"Drug Metab. Pharmacokinet."},{"issue":"11","key":"10.1016\/j.ejps.2025.107036_bib0282","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.bcp.2010.01.028","article-title":"Characterization of major phytocannabinoids, cannabidiol and cannabinol, as isoform-selective and potent inhibitors of human CYP1 enzymes","volume":"79","author":"Yamaori","year":"2010","journal-title":"Biochem. Pharmacol."},{"issue":"11","key":"10.1016\/j.ejps.2025.107036_bib0283","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.bcp.2010.01.028","article-title":"Characterization of major phytocannabinoids, cannabidiol and cannabinol, as isoform-selective and potent inhibitors of human CYP1 enzymes","volume":"79","author":"Yamaori","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejps.2025.107036_bib0284","article-title":"Potential impact of Thailand's cannabis policy on the health of young adults: current status and future landscape","volume":"10","author":"Yimsaard","year":"2023","journal-title":"Lancet Reg. Heal. - Southeast Asia"},{"issue":"8","key":"10.1016\/j.ejps.2025.107036_bib0285","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/pca.3188","article-title":"A reliable quantitative method for determining CBD content and release from transdermal patches in Franz cells","volume":"33","author":"Yu","year":"2022","journal-title":"Phytochem. Anal."},{"issue":"1","key":"10.1016\/j.ejps.2025.107036_bib0286","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1476-5381.2009.00521.x","article-title":"Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors","volume":"159","author":"Zanelati","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejps.2025.107036_bib0287","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1476-5381.2009.00521.x","article-title":"Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT 1A receptors","volume":"159","author":"Zanelati","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejps.2025.107036_bib0288","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2174\/1389200217666151210142051","article-title":"Cannabinoids and cytochrome P450 interactions","volume":"17","author":"Zendulka","year":"2016","journal-title":"Curr. Drug Metab."},{"issue":"4","key":"10.1016\/j.ejps.2025.107036_bib0289","first-page":"239","article-title":"The pharmacological basis for application of cannabidiol in cancer chemotherapy","volume":"67","author":"Zhelyazkova","year":"2020","journal-title":"Pharm"},{"issue":"5","key":"10.1016\/j.ejps.2025.107036_bib0290","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3390\/ph5050529","article-title":"Cannabidiol in humans\u2014The quest for therapeutic targets","volume":"5","author":"Zhornitsky","year":"2012","journal-title":"Pharmaceuticals"},{"issue":"4","key":"10.1016\/j.ejps.2025.107036_bib0291","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000137442","article-title":"Influence of cannabinoids on somatic cells in vivo","volume":"21","author":"Zimmerman","year":"1980","journal-title":"Pharmacology"},{"issue":"11","key":"10.1016\/j.ejps.2025.107036_bib0292","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1096\/fj.201600646R","article-title":"Cannabinoids, inflammation, and fibrosis","volume":"30","author":"Zurier","year":"2016","journal-title":"FASEB J."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725000351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725000351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T06:18:24Z","timestamp":1742365104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098725000351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":292,"alternative-id":["S0928098725000351"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107036","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabidiol\u2014A friend or a foe?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107036"}}